These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21793834)

  • 21. NF-kappaB in solid tumors.
    Pacifico F; Leonardi A
    Biochem Pharmacol; 2006 Oct; 72(9):1142-52. PubMed ID: 16956585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of activated nuclear factor-kappaB in the pathogenesis and therapy of squamous cell carcinoma of the head and neck.
    Allen CT; Ricker JL; Chen Z; Van Waes C
    Head Neck; 2007 Oct; 29(10):959-71. PubMed ID: 17405170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. META060 inhibits multiple kinases in the NF-kappaB pathway and suppresses LPS--mediated inflammation in vitro and ex vivo.
    Desai A; Konda VR; Darland G; Austin M; Prabhu KS; Bland JS; Carroll BJ; Tripp ML
    Inflamm Res; 2009 May; 58(5):229-34. PubMed ID: 19169645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation.
    Viatour P; Merville MP; Bours V; Chariot A
    Trends Biochem Sci; 2005 Jan; 30(1):43-52. PubMed ID: 15653325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycine-extended gastrin stimulates proliferation and inhibits apoptosis in colon cancer cells via cyclo-oxygenase-independent pathways.
    Ogunwobi OO; Beales IL
    Regul Pept; 2006 Mar; 134(1):1-8. PubMed ID: 16169610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual apoptotic effect of Xrel3 c-Rel/NF-kappaB homolog in human cervical cancer cells.
    Shehata M; Shehata M; Shehata F; Pater A
    Cell Biol Int; 2004; 28(12):895-904. PubMed ID: 15566959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel caffeic acid ester derivative induces apoptosis by expressing FasL and downregulating NF-KappaB: Potentiation of cell death mediated by chemotherapeutic agents.
    Bose JS; Gangan V; Jain SK; Manna SK
    J Cell Physiol; 2009 Mar; 218(3):653-62. PubMed ID: 19034929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decursinol angelate blocks transmigration and inflammatory activation of cancer cells through inhibition of PI3K, ERK and NF-kappaB activation.
    Kim WJ; Lee MY; Kim JH; Suk K; Lee WH
    Cancer Lett; 2010 Oct; 296(1):35-42. PubMed ID: 20381234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-inflammatory function of Withangulatin A by targeted inhibiting COX-2 expression via MAPK and NF-kappaB pathways.
    Sun L; Liu J; Cui D; Li J; Yu Y; Ma L; Hu L
    J Cell Biochem; 2010 Feb; 109(3):532-41. PubMed ID: 19950196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor suppressive effects of tocotrienol in vivo and in vitro.
    Wada S; Satomi Y; Murakoshi M; Noguchi N; Yoshikawa T; Nishino H
    Cancer Lett; 2005 Nov; 229(2):181-91. PubMed ID: 16098658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential role of NF-kappaB in esophageal adenocarcinoma: as an emerging molecular target.
    Abdel-Latif MM; Kelleher D; Reynolds JV
    J Surg Res; 2009 May; 153(1):172-80. PubMed ID: 18533190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Marine natural products as targeted modulators of the transcription factor NF-kappaB.
    Folmer F; Jaspars M; Dicato M; Diederich M
    Biochem Pharmacol; 2008 Feb; 75(3):603-17. PubMed ID: 17919455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential role of tocotrienols in the treatment and prevention of breast cancer.
    Sylvester PW; Akl MR; Malaviya A; Parajuli P; Ananthula S; Tiwari RV; Ayoub NM
    Biofactors; 2014; 40(1):49-58. PubMed ID: 23804535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of NF-kappaB in the anti-inflammatory effects of tocotrienols.
    Kaileh M; Sen R
    J Am Coll Nutr; 2010 Jun; 29(3 Suppl):334S-339S. PubMed ID: 20823493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The potential contributions of chronic inflammation to lung carcinogenesis.
    Ballaz S; Mulshine JL
    Clin Lung Cancer; 2003 Jul; 5(1):46-62. PubMed ID: 14596704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammation and gastrointestinal cancer: an overview.
    Marusawa H; Jenkins BJ
    Cancer Lett; 2014 Apr; 345(2):153-6. PubMed ID: 23981579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. E2F1 and NF-κB: Key Mediators of Inflammation-associated Cancers and Potential Therapeutic Targets.
    Huang Y; Chen R; Zhou J
    Curr Cancer Drug Targets; 2016; 16(9):765-772. PubMed ID: 26881929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Why cancer and inflammation?
    Rakoff-Nahoum S
    Yale J Biol Med; 2006 Dec; 79(3-4):123-30. PubMed ID: 17940622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting the inflammatory pathways to enhance chemotherapy of cancer.
    Zhu Z; Zhong S; Shen Z
    Cancer Biol Ther; 2011 Jul; 12(2):95-105. PubMed ID: 21623164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammation and cancer: an ancient link with novel potentials.
    Hussain SP; Harris CC
    Int J Cancer; 2007 Dec; 121(11):2373-80. PubMed ID: 17893866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.